Theravance Biopharma
TBPH
TBPH
133 hedge funds and large institutions have $512M invested in Theravance Biopharma in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 54 increasing their positions, 31 reducing their positions, and 20 closing their positions.
Holders
133
Holders Change
+2
Holders Change %
+1.53%
% of All Funds
1.79%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
23
Increased
54
Reduced
31
Closed
20
Calls
$3K
Puts
$158K
Net Calls
-$155K
Net Calls Change
-$145K
Top Buyers
| 1 |
1
BlackRock
New York
|
$45.7M |
| 2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$5.55M |
| 3 |
JFG
3
Jefferies Financial Group
New York
|
$3.05M |
| 4 |
NM
4
Newtyn Management
New York
|
$54.6M |
| 5 |
5
Morgan Stanley
New York
|
$6.07M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
QCG
151
Quadrant Capital Group
Cincinnati,
Ohio
| – | – | -335 | Closed |
|
|
SAM
152
Smartleaf Asset Management
Boston,
Massachusetts
| – | – | -53 | Closed |
|
|
CA
153
CoreCap Advisors
Southfield,
Michigan
| – | – | -27 | Closed |
|
|
TWD
154
True Wealth Design
Akron,
Ohio
| – | – | -3 | Closed |
|
155
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|